Cited by 163Cervical Cancer and HPV ResearchReproductive tract infections researchWomen's cancer prevention and management

Papillomavirus infection in rural women in southern India

Open access
Franceschi, S, Rajkumar, R, Snijders, P J F, Arslan, A, Mahé, C, Plummer, M, Sankaranarayanan, R, Cherian, J +2 more·2005·British Journal of Cancer

Abstract

To investigate the prevalence of, and the risk factors for, cervical infection with 44 types of human papillomavirus (HPV) in a rural area in the Dindigul District, Tamil Nadu, India, we interviewed and obtained cervical cell samples from 1891 married women aged 16-59 years. HPV prevalence was 16.9% overall and 14.0% among women without cervical abnormalities, or 17.7 and 15.2%, respectively, age-standardised to the world standard population. In all, 21.9% of infections involved more than one HPV type. High-risk HPV types predominated, particularly HPV 16 (22.5% of women infected), followed by HPV 56, HPV 31, HPV 33 and HPV 18. Unlike most populations studied in developed countries, HPV prevalence was constant across the age groups. HPV positivity was inversely associated with education level (odds ratio (OR) among women with high school vs no education=0.6) and positively associated with widowhood and divorce (OR=1.7), nulligravidity (OR=2.3), and condom use (OR=2.6). It is unclear how much low clearance of, or frequent reinfection with HPV accounted for the study prevalence of infection in different age groups.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/sj.bjc.6602348

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • EpiMetHeos was calibrated to Tamil Nadu to represent states in the high cervical cancer incidence cluster and to West Bengal to represent states in the low cervical cancer incidence cluster.

    “we calibrated EpiMetHeos to the state of Tamil Nadu to represent the states in the high cancer incidence cluster, and the state of West Bengal to represent the states in the low cancer incidence cluster”

    From Evidence-based impact projections of single-dose human papillomavirus vaccination in India: a modelling study (2022) · cites this paper as [19]

    Materials and Methods identifies the study site as Dindigul District, Tamil Nadu, and the Discussion compares its HPV prevalence with that in high-risk cervical-cancer areas. The Discussion also mentions a West Bengal HPV survey, but does not classify West Bengal as a low-incidence state or establish high- and low-incidence state clusters. The EpiMetHeos calibration is the citing authors’ own action, not a finding of this source. (LLM, conf=0.78)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 17 · Cited by 163

Research works printed but not linked: 17

  1. Anh PT, Hieu NT, Herrero R, Vaccarella S, Smith JS, Thuy NT, Nga NH, Duc NB, Ashley R, Snijders PJ, Meijer CJ, Muñoz N, Parkin DM, Franceschi S (2003) Human papillomavirus infection among women in South and North Vietnam. Int J Cancer 104: 213–220 12569577
  2. Bulk S, Van Kemenade FJ, Rozendaal L, Meijer CJ (2004) The Dutch CISOE – a framework for cytology reporting increases efficacy of screening upon standardisation since 1996. J Clin Pathol 57: 388–393 15047743 PMC1770272
  3. Clifford GM, Smith JS, Plummer M, Muñoz N, Franceschi S (2003) Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 88: 63–73 12556961 PMC2376782
  4. Department of Health (2000) Department of Health Bulletin 2000/30, Cervical Screening Programme, England, 1999–2000, November 2000
  5. de Sanjosé S, Almirall R, Lloveras B, Font R, Diaz M, Muñoz N, Catala I, Meijer CJ, Snijders PJ, Herrero R, Bosch FX (2003) Cervical human papillomavirus infection in the female population in Barcelona, Spain. Sex Transm Dis 30: 788–793 14520179
  6. Duttagupta C, Sengupta S, Roy M, Sengupta D, Bhattacharya P, Laikangbam P, Roy S, Ghosh S, Das R (2004) Are Muslim women less susceptible to oncogenic human papillomavirus infection? A study from rural eastern India. Int J Gynecol Cancer 14: 293–303 15086729
  7. Franceschi S, Rajkumar T, Vaccarella S, Gajalakshmi V, Sharmila A, Snijders PJ, Muñoz N, Meijer CJ, Herrero R (2003) Human papillomavirus and risk factors for cervical cancer in Chennai, India: a case–control study. Int J Cancer 107: 127–133 12925967
  8. Matos E, Loria D, Amestoy G, Herrera L, Prince MA, Moreno J, Krunfly C, van den Brule AJ, Meijer CJ, Muñoz N, Herrero R, Proyecto Concordia Collaborative Group (2003) Prevalence of human papillomavirus infection among women in Concordia, Argentina: a population-based study. Sex Transm Dis 30: 593–599 12897679
  9. Molano M, Posso H, Weiderpass E, van den Brule AJ, Ronderos M, Franceschi S, Meijer CJ, Arslan A, Muñoz N (2002) Prevalence and determinants of HPV infection among Colombian women with normal cytology. Br J Cancer 87: 324–333 12177803 PMC2364213
  10. Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah KV, Snijders PJ, Meijer CJ (2003) Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348: 518–527 12571259
  11. Peto J, Gilham C, Deacon J, Taylor C, Evans C, Binns W, Haywood M, Elanko N, Coleman D, Yule R, Desai M (2004) Cervical HPV infection and neoplasia in a large population-based prospective study: the Manchester cohort. Br J Cancer 91: 942–953 15292939 PMC2409880
  12. Rajkumar R, Sankaranarayanan R, Esmi A, Jayaraman R, Cherian J, Parkin DM (2000) Leads to cancer control based on cancer patterns in a rural population in South India. Cancer Causes Control 11: 433–439 10877336
  13. Ronco G, Ghisetti V, Segnan N, Snijders PJF, Gillio-Tos A, Meijer CJLM, Merletti F, Franceschi S (2005) Prevalence of papillomavirus infection in women in Turin, Italy. Eur J Cancer (in press) 15661556
  14. Sankaranarayanan R, Rajkumar R, Theresa R, Esmy PO, Mahé C, Bagyalakshmi KR, Thara S, Frappart L, Lucas E, Muwonge R, Shanthakumari S, Jeevan D, Subbarao TM, Parkin DM, Cherian J (2004) Initial results from a randomized trial of cervical visual screening in rural south India. Int J Cancer 109: 461–467 14961588
  15. Shin HR, Lee DH, Herrero R, Smith JS, Vaccarella S, Hong SH, Jung KY, Kim HH, Park UD, Cha HS, Park S, Touze A, Muñoz N, Snijders PJ, Meijer CJ, Coursaget P, Franceschi S (2003) Prevalence of human papillomavirus infection in women in Busan, South Korea. Int J Cancer 103: 413–421 12471626
  16. Thomas JO, Herrero R, Omigbodun AA, Ojemakinde K, Ajayi IO, Fawole A, Oladepo O, Smith JS, Arslan A, Muñoz N, Snijders PJ, Meijer CJ, Franceschi S (2004) Prevalence of papillomavirus infection in women in Ibadan, Nigeria: a population-based study. Br J Cancer 90: 638–645 14760378 PMC2409602
  17. van den Brule AJ, Pol R, Fransen-Daalmeijer N, Schouls LM, Meijer CJ, Snijders PJ (2002) GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J Clin Microbiol 40: 779–787 11880393 PMC120256

Authors
Franceschi, S., Rajkumar, R., Snijders, P. J. F., Arslan, A., Mahé, C., Plummer, M., Sankaranarayanan, R., Cherian, J., Meijer, C. J. L. M., & Weiderpass, E.
Affiliations
  • Centre international de recherche sur le cancer (FR)
  • Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
  • Karolinska Institutet (SE)
Corresponding author
Franceschi, S
Venue
British Journal of Cancer
Published
2005-01-25
Volume
92
Issue
3
Pages
601-606
ISSN
  • 0007-0920 (ISSN-L)
  • 1532-1827
OpenAlex
W2050553573
Cited by
163
References
17
Citations by year
2026: 5 · 2025: 3 · 2024: 8 · 2023: 8 · 2022: 5 · 2021: 11 · 2020: 4 · 2019: 7 · 2018: 3 · 2017: 3 · 2016: 10 · 2015: 5 · 2014: 4 · 2013: 7 · 2012: 12
FWCI
9.61
Type
journal article
Language
en
Open access
Locations
  • British Journal of Cancer (publishedVersion, cc-by-nc-sa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion, other-oa)
  • Pure Amsterdam UMC (submittedVersion, other-oa)
  • Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam) (submittedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
Funders
Swiss Bridge Foundation
Topics
  • Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
  • Life Sciences › Immunology and Microbiology › Microbiology › Reproductive tract infections research
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Women's cancer prevention and management
Keywords
human papillomavirus, HPV prevalence, cervical infection, rural women, risk factors, HPV16, multiple HPV infection, high-risk HPV, educational attainment, marital status, condom use, Dindigul district
MeSH terms
Adolescent, Adult, Uterine Cervical Diseases, DNA, Viral, Educational Status, Female, Humans, India, Middle Aged, Rural Population, Vaginal Smears, Prevalence, Papillomavirus Infections

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review